Researchers are intrigued by the potential benefits psilocybin offers mushrooms, with theories ranging from a defense mechanism against predators to a deterrent for terrestrial slugs following the post-dinosaur extinction ice age.
Like this:
LikeLoading…
A groundbreaking study by the University of Utah and the Natural History Museum of Utah reveals that psilocybin mushrooms, known for their psychoactive properties, have existed for approximately 65 million years, dating back to the era of dinosaur extinction. This research, the largest genomic diversity study for the Psilocybe genus, uncovers the ancient evolutionary history of these mushrooms and their potential implications for modern psilocybin medicine.
The resurgence of interest in psilocybin, the psychoactive compound found in magic mushrooms, for mental health treatment has led researchers to delve into the evolutionary history of these fungi. A recent study published in the Proceedings of the National Academy of Sciences suggests that psilocybin mushrooms have been around for about 65 million years, coinciding with the extinction of dinosaurs. This discovery stems from the largest genomic diversity study on the Psilocybe genus, involving 52 specimens, including 39 species that had not been previously sequenced.
The study identified two distinct gene orders responsible for psilocybin production, indicating two independent evolutionary paths for the compound’s development. This finding not only highlights the ancient origins of psilocybin mushrooms but also suggests a wealth of genetic diversity that could benefit the future development of psilocybin-based therapeutics.
Researchers are intrigued by the potential benefits psilocybin offers mushrooms, with theories ranging from a defense mechanism against predators to a deterrent for terrestrial slugs following the post-dinosaur extinction ice age. The study’s findings pave the way for further research into the evolutionary role of psilocybin and its applications in modern medicine.
Why It Matters: Understanding the ancient origins and evolutionary history of psilocybin mushrooms provides valuable insights into their potential therapeutic benefits. This research could revolutionize the development of psilocybin-based treatments, offering new avenues for addressing mental health issues.
Potential Implications: The study’s revelations about the genetic diversity of psilocybin-producing mushrooms could significantly impact the future of psychedelic medicine. By exploring different gene sequences for psilocybin production, scientists may develop more effective and tailored treatments for various mental health conditions.
In a significant breakthrough for the fields of pest control and natural insecticides, a recent study has revealed that CBD (cannabidiol), a compound derived from hemp plants, has the ability to kill mosquitoes, mainly mosquito larvae, including those resistant to conventional insecticides. Published by researchers at Ohio State University, the study explored the effects of hemp leaf extracts, that contains CBD, on the larvae of the yellow fever mosquito (Aedes aegypti), which is responsible for transmitting diseases like Zika, dengue, and yellow fever. This finding represents an exciting new avenue for sustainable mosquito control, especially as global efforts to combat pesticide resistance intensify.
CBD: A New Weapon Against Deadly Mosquitoes
The Growing Problem of Insecticide Resistance
Mosquitoes are among the deadliest animals in the world, killing more than 1 million people annually through the transmission of mosquito-borne diseases. Over the past few decades, mosquitoes have developed resistance to many synthetic insecticides, such as pyrethroids and organophosphates, which have been overused in both agricultural and public health applications. As these chemicals lose their effectiveness, there is an urgent need to find alternative, environmentally friendly pest control methods.
The development of insecticide resistance is particularly alarming because it leads to higher transmission rates of deadly diseases. Public health organizations like the World Health Organization (WHO) have highlighted the need for innovative solutions that target mosquitoes at their most vulnerable life stage: the larvae. This is where CBD could play a transformative role.
CBD as a Natural Insecticide: The Study
The Ohio State University research team created an extract from hemp leaves by soaking them in methanol. When this extract, containing CBD, was applied to mosquito larvae in a controlled setting, it killed all of the larvae within 48 hours. What surprised the researchers was the minimal concentration of CBD needed to achieve this high level of mortality, even in mosquito larvae that had developed resistance to conventional insecticides.
CBD’s mode of action appears to bypass the metabolic resistance mechanisms that protect mosquito larvae from synthetic chemicals. Unlike synthetic insecticides, which often rely on overwhelming the insect’s nervous system, CBD may interfere with protein interactions and cellular processes unique to mosquitoes, offering a novel way to target these pests.
Benefits of Hemp-Derived CBD as an Insecticide
CBD as an insecticide offers several distinct advantages over traditional chemicals:
Sustainability: Hemp is a renewable resource that requires relatively few inputs, such as pesticides and fertilizers, making it an environmentally sustainable crop. Hemp has also gained attention for its ability to rejuvenate soil and sequester carbon, adding to its eco-friendly appeal.
Cost-Effectiveness: Hemp cultivation has surged in recent years, particularly due to the popularity of CBD-based wellness products. This increase in hemp farming creates a byproduct in the form of hemp leaves, which could be repurposed for pest control, reducing waste and making the production of CBD-based insecticides cost-efficient.
Targeted Control: Traditional insecticides often have broad-spectrum effects, meaning they can harm non-target species such as bees, butterflies, and other important pollinators. Early indications suggest that CBD is more selective, primarily targeting mosquito larvae while leaving other species unharmed. However, further studies are necessary to confirm this selectivity and ensure minimal environmental impact.
Human and Animal Safety: CBD is widely regarded as safe for human and animal consumption, a property that extends to its potential use as an insecticide. Many chemical insecticides are harmful to both people and the environment, but CBD does not share the same toxic profile. This makes it an attractive alternative for use in urban environments, where human exposure to pest control agents is high.
Environmental Considerations and Potential Drawbacks
While the potential for CBD-based insecticides is exciting, there are also important environmental concerns that need to be addressed. Hemp is a rapidly growing crop, but large-scale production of hemp-derived CBD for pest control could have ecological consequences if not properly managed.
One concern is the impact on aquatic ecosystems. Mosquito larvae thrive in standing water, so any compound used to control them would likely enter these water systems. Researchers have warned that further studies are needed to assess the long-term effects of CBD on non-target aquatic organisms, such as fish, amphibians, and invertebrates. While CBD is generally safe for mammals, it may have unintended consequences in ecosystems that rely on delicate balances between species.
Additionally, there is the issue of ensuring that the production of CBD for insecticidal use does not interfere with hemp’s biodiversity-friendly characteristics. As with any crop, scaling up production can have negative effects if not done sustainably, such as through the overuse of land, water, and fertilizers.
Broader Applications and Future Research Directions
The discovery of CBD’s insecticidal properties could extend beyond mosquito control. Researchers are now exploring whether CBD can be used against other agricultural pests, such as aphids, mites, and whiteflies, which cause billions of dollars in crop damage worldwide each year. If successful, CBD could become an essential tool in organic farming and integrated pest management strategies, helping to reduce the reliance on synthetic pesticides that damage soil health and biodiversity.
Another area of interest is genetic engineering, where scientists could potentially enhance the insecticidal properties of hemp plants, allowing them to produce higher concentrations of CBD or other cannabinoids that have pest-controlling effects. Such advancements could lead to the development of biopesticides that are even more effective and easier to produce.
State of Research on Natural Insecticides
CBD’s success as an insecticide is part of a growing trend toward using natural compounds to control pests. Natural insecticides, such as those derived from neem oil, pyrethrin, and bacillus thuringiensis (Bt), are already widely used in organic farming and public health initiatives. These substances are favored for their biodegradability and lower toxicity compared to synthetic alternatives.
However, CBD could offer a key advantage over these other natural insecticides by targeting resistant mosquito species, which have become a major problem for global public health efforts. The next steps in research will focus on fine-tuning CBD’s application methods, determining optimal dosages, and ensuring that it can be produced and deployed at scale without negative environmental impacts.
Conclusion: A Promising Future for CBD-Based Pest Control
The discovery of CBD’s ability to kill mosquito larvae opens up exciting possibilities for the future of natural pest control. As traditional insecticides lose their effectiveness and the environmental toll of chemical pesticides becomes more apparent, solutions like CBD-based insecticides could revolutionize the way we manage pest populations. With its sustainability, safety, and potential to target pesticide-resistant species, CBD could become a cornerstone of eco-friendly pest management.
However, as with any new technology, further research is needed to fully understand the long-term impacts and ensure that the benefits of CBD-based insecticides are maximized without compromising the environment. In the meantime, the hemp industry continues to grow, potentially transforming from a source of wellness products to a critical player in the global fight against pests.
Canadian sales of recreational cannabis rose to 448.6 million Canadian dollars in October ($336 million), marking a small increase from the previous month and a 15% increase over the same period last year.
By comparison, sales fell 6.2% in September on a month-over-month basis.
The new data from Statistics Canada shows that CA$4.2 billion worth of cannabis was sold in Canada through the first 10 months of 2023, which was 26% more than in January-October 2022.
Ontario continued to lead the country with CA$177.7 million in sales in October, or 1% more than September.
Alberta was next with CA$76.4 million in sales, about the same as the month before.
In the remaining provinces, monthly marijuana sales in October 2023 and comparisons to sales in September 2023 were:
British Columbia: CA$70.9 million (even).
Quebec: CA$57.5 million (+7.7%).
Manitoba: CA$18.8 million (+9%).
Nova Scotia: CA$10.2 million (+3.2%).
New Brunswick: CA$7.5 million (+2.7%).
Newfoundland: CA$7.3 million (+1.2%).
Prince Edward Island: CA$2.1 million (+3%).
Saskatchewan: CA$17.7 million (+9%).
Yukon: CA$1.1 million (even).
By municipality, Toronto and Montreal recorded the highest October sales.
Toronto’s sales were CA$58.7 million, a 1.2% month-over-month increase.
Montreal’s sales were CA$31 million, up 7.7% versus September.
Cannabis retail sales in select Canadian cities and monthly sales changes were:
Edmonton, Alberta: CA$25.7 million (even).
Vancouver, British Columbia: CA$23.1 million (+1.5%).
Calgary, Alberta: CA$21.3 million (+1%).
Ottawa, Ontario: CA$16 million (even).
Winnipeg, Manitoba: CA$11.5 million (+9%).
Quebec City: CA$5.1 million (+7.7%).
Gatineau, Quebec: CA$1.4 million (+7.7%).
Statistics Canada’s cannabis retail sales data is available here.
A letter from California Attorney General Rob Bonta to state regulators all but ended marijuana industry hopes of interstate cannabis commerce.
In a 36-page letter sent Dec. 19 to the Department of Cannabis Control (DCC), the state’s chief cannabis regulator, Bonta wrote that marijuana activity between legal out-of-state businesses and California licensees could result in “significant legal risk to the State of California under the federal Controlled Substances Act.”
The warning – first reported by Marijuana Moment – is not a surprise, considering federal prohibition of the plant, which cast long odds a state law allowing such sales would be put to the test.
California hopes for interstate cannabis sales rose in September 2022, when Gov. Gavin Newsom signed Senate Bill 1326to create interstate commerce pacts, overriding a longstanding prohibition on the transportation and distribution of marijuana products across state lines.
Enactment of the law, however, was contingent on several triggers, including federal legalization, approvals from the Department of Justice and other major U.S. marijuana policy shifts.
SB 1326 went into effect on Jan. 1 2023, and shortly thereafter, the DCC asked Bonta, a longtime industry advocate as an Assembly member, to provide some guidance on interstate sales.
In a statement sent to MJBizDaily and other news outlets, the DCC said that “we appreciate the attorney general’s conclusion that the arguments supporting interstate agreements are strong. Unfortunately, even strong arguments cannot put novel questions beyond all debate.”
Bonta’s response also made a passing reference to protecting state employees who might be open to legal risks by greenlighting interstate cannabis commerce.
“Courts have disagreed about the scope of federal preemption in the cannabis context, and no court has ever considered a preemption challenge to a state law authorizing interstate cannabis sales,” the letter noted.
“The law is also unsettled as to whether state officials could be federally prosecuted for implementing state law in this area.”
In May, Washington became the third state to create an interstate cannabis commerce law, thought the statute also was contingent on the U.S. government legalizing marijuana or allowing such transactions between states.
Oregon became the first state with an interstate marijuana commerce provision in June 2019 when its governor signed such activity into law.